KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $24.5 million.

  • Charles River Laboratories International's Change in Account Payables rose 381866.46% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year increase of 348758.83%. This contributed to the annual value of -$14.3 million for FY2024, which is 3013.66% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Change in Account Payables is $24.5 million, which was up 381866.46% from -$9.0 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Change in Account Payables peaked at $40.9 million during Q1 2022, and registered a low of -$41.3 million during Q2 2023.
  • Over the past 5 years, Charles River Laboratories International's median Change in Account Payables value was -$659000.0 (recorded in 2024), while the average stood at $2.5 million.
  • The largest annual percentage gain for Charles River Laboratories International's Change in Account Payables in the last 5 years was 381866.46% (2025), contrasted with its biggest fall of 52802.85% (2025).
  • Quarter analysis of 5 years shows Charles River Laboratories International's Change in Account Payables stood at $33.5 million in 2021, then plummeted by 125.79% to -$8.6 million in 2022, then surged by 170.72% to $6.1 million in 2023, then crashed by 217.56% to -$7.2 million in 2024, then skyrocketed by 441.5% to $24.5 million in 2025.
  • Its Change in Account Payables was $24.5 million in Q3 2025, compared to -$9.0 million in Q2 2025 and $25.3 million in Q1 2025.